Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Convatec GroupCNVVY -2.56%77 Market Cap is $5,557 Mil as of Jul. 24, 2026. GuruFocus rates CNVVY with a GF Score™ of 77/100 and a GF Value™ of $13.81 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 864 Medical Devices & Instruments companies, Convatec Group ranks better than 93.98% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Convatec Group's share price for the quarter that ended in Dec. 2025 was $13.07. Convatec Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 489 Mil. Therefore, Convatec Group's market cap for the quarter that ended in Dec. 2025 was $6,386 Mil.
Convatec Group's quarterly market cap
increased
from Dec. 2024 ($5,847 Mil) to Jun. 2025 ($8,351 Mil) but then
declined
from Jun. 2025 ($8,351 Mil) to Dec. 2025 ($6,386 Mil).
Convatec Group's annual market cap
declined
from Dec. 2023 ($6,424 Mil) to Dec. 2024 ($5,847 Mil) but then
increased
from Dec. 2024 ($5,847 Mil) to Dec. 2025 ($6,386 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Convatec Group's Enterprise Value for Today is $6,907 Mil.
Convatec Group (OTCPK:CNVVY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Convatec Group Market Cap Related Terms
Convatec Group Market Cap Historical Data
* Premium members only.
The historical data trend for Convatec Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Convatec Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Convatec Group Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Convatec Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Convatec Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Convatec Group (CNVVY) has a Market Cap of $5,557 Mil as of Jul. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Convatec Group and its competitors. According to the industry distribution chart, Convatec Group ranks #52 out of 864 companies in the Medical Devices & Instruments industry, placing it in the top 6%.
Is Convatec Group's Market Cap too high?
Convatec Group's current Market Cap is $5,557 Mil. The Medical Devices & Instruments industry median Market Cap is 113.06. Convatec Group's value of $5,557 Mil is 4815% above this industry median. Based on the distribution chart, Convatec Group ranks #52 out of 864 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Convatec Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Convatec Group ranks #52 out of 864 companies for Market Cap. This places Convatec Group in the top 6% of its industry — outperforming the majority of peers. The industry median Market Cap is 113.06. Convatec Group's value of $5,557 Mil is 4815% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 113.06, based on 864 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Convatec Group's current Market Cap of $5,557 Mil is 4815% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Convatec Group and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 113.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Convatec Group's current Market Cap is $5,557 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Based on GuruFocus' analysis, Convatec Group (CNVVY) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.81, compared to a current price of $11.40 — trading 17.5% below its estimated fair value. The current Market Cap is $5,557 Mil and 4815% above the Medical Devices & Instruments industry median of 113.06. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Convatec Group (CNVVY), the current Market Cap is $5,557 Mil as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Convatec Group (CNVVY) Overvalued in 2026?
Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued.
The current stock price of $11.40 is trading 17.5% below its estimated GF Value™ of $13.81.
GuruFocus considers Convatec Group to be Modestly Undervalued.
Key valuation signals for CNVVY:
Market Cap: $5,557 Mil
GF Value™: $13.81 vs. price of $11.40 (17.5% below fair value)
Industry Position: 4815% above the Medical Devices & Instruments median (#52 of 864)
No single metric tells the full story. See the CNVVY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score
Get the complete analysis for CNVVY
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CNVVY has been successfully added to your 
